BICILLIN L-A benzathine benzylpenicillin tetrahydrate 1,200,000 Units / 2.3 mL suspension for injection pre-filled syringe with needle

Reason reported to TGA

Manufacturing

TGA management action

Health professionals are encouraged to consider reserving any remaining Australian-registered Bicillin L-A stock held within their services for paediatric patients. Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. The TGA has published a web statement outlining key information about the shortage which is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-bicillin-l-benzathine-benzylpenicillin-tetrahydrate-prefilled-syringe-injection

What to do

1. 1.
   Contact your pharmacist — Your pharmacist can check stock and whether another pharmacy can supply this product.
2. 2.
   Ask your doctor before switching — A prescriber can decide whether another product is appropriate. Do not change medicines on your own.
3. 3.
   Check the TGA report — The TGA Medicine Shortage Reports Database is the source for the dates and management action on this page.